PSCH vs XLV

PSCHBInvesco S&P SmallCap Health Care ETF

XLVAState Street Health Care Select Sector SPDR ETF

In short

PSCH Health care, minus the mega-cap pharma giants. PSCH tracks a capped small-cap health care index from the S&P SmallCap 600: roughly 70 companies, same sector as the household-name funds, opposite end of the size spectrum, for 0.29% a year.

XLV Live since 1998, XLV is the original way to own health care: about 60 S&P 500 names, a 0.08% fee, and one of the busiest tickers in the sector. Big pharma and device makers, not small-cap biotech.

Stated mandate

PSCH The Fund is based on the S&P SmallCap 600® Capped Health Care Index and normally invests at least 90% of its assets in securities represented by that Index.

XLV The fund seeks to track, before expenses, the price and yield performance of the Health Care Select Sector Index, which represents the health care sector of the S&P 500 Index.

Why people hold it

• PSCH Charges 0.29% a year, well below the median fee in its broad health care peer group. Cheap access to the small-cap corner of the sector.
• Rules-based and plain: normally at least 90% of assets in the securities of the S&P SmallCap 600 Capped Health Care Index, roughly 70 names, with index caps limiting how large any one position gets.
• Running since 2010, through multiple biotech boom-and-bust cycles, and one of the stronger builds among the two dozen broad health care ETFs we track.

• XLV 0.08% a year against a cohort median of 0.50%. That ties it with FHLC as the cheapest in the group and edges VHT at 0.09%.
• One of the most actively traded funds in its category, which generally keeps bid-ask spreads thin whether you trade 10 shares or 10,000.
• Launched December 1998 as one of the first US sector funds, and it has tracked its S&P 500 health care index closely ever since.
• Covers the whole sector in one line: pharma, devices, providers, biotech, life-science tools and health tech. Pays quarterly.ssga.com

Worth knowing

• PSCH Trades lightly next to the mega-cap sector funds, so bid-ask spreads and market impact matter more here, particularly in size or in a fast-moving market.
• Small-cap health care is the jumpy end of the sector, and a roughly 70-stock lineup means single-company news lands harder than in a sprawling mega-cap fund.
• Distributions come once or twice a year, not monthly. This is a sector equity sleeve, not an income-first holding.

• XLV Cap-weighted and about 60 names deep, so the largest drug and device makers carry most of the weight.ssga.com
• S&P 500 members only. Mid- and small-cap health care names sit outside the mandate.
• One sector, one set of headlines: drug pricing rules, patent expirations and policy shifts move the whole basket together.

Full PSCH profile⁠

Full XLV profile⁠